sbla news - Search News

sBLA, Dupixent

Sanofi, Regeneron Dupixent sBLA accepted for USFDA review for chronic spontaneous urticaria

Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA)

Pharmabiz · 1h

US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria

US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin

Monthly Prescribing Reference · 2d

FDA to Review Resubmitted Dupilumab sBLA for Chronic Spontaneous Urticaria

The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.

Business Insider · 2d

Regeneron, Sanofi announce FDA accepts Dupixent sBLA for review

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License

MarketWatch · 2d

Regeneron, Sanofi Get New FDA Review of Dupixent for CSU

Regeneron Pharmaceuticals and Sanofi said the U.S. Food and Drug Administration has accepted their resubmitted application seeking expanded approval of the blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic spontaneous urticaria,

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

SBLA Beauty Liquid Facelift Wand Awarded “Serum Product Of The Year” In 2024 Beauty Innovation Awards

Annual Awards Program Recognizes Top Companies, Services and Products Within the Global Beauty IndustryLOS ANGELES, Nov. 14, ...

FDA Cellular, Tissue & Gene Therapies Advisory Committee holds virtual meeting

The Committee discusses and makes recommendations for AstraZeneca (AZN) supplemental Biologics License Application (sBLA) 125586/546 for ...

10h

This celebrity-approved SLBA anti-aging eye treatment is 40% off ahead of Black Friday — 'it really works,' say shoppers

One popular item that shoppers rave about is the celeb-approved Eye Lift Wand from SBLA Beauty. Marketed as "the first-ever ...

Yahoo Finance3d

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results